Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis.
Hauser SL, Kappos L, Montalban X, Craveiro L, Chognot C, Hughes R, Koendgen H, Pasquarelli N, Pradhan A, Prajapati K, Wolinsky JS.. Wiley Interdiscip Rev Dev Biol. 2013 Jan-Feb;2(1):17-29. doi: 10.1002/wdev.68. Epub 2012 May 14. Wiley Interdiscip Rev Dev Biol. 2013. PMID: 23799628 Review..
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
